A Prospective, Randomized, Open-Label Study Comparing the Efficacy and Safety of Clonazepam versus Nortriptyline on Quality of Life in 40+ Years old Women Presenting with Restless Leg Syndrome

Introduction: Restless legs syndrome (RLS) is a neurological disorder characterized by an urge to move the legs usually accompanied by unpleasant leg sensations. RLS also impacts health related quality of life (QOL) in patients suffering from it. Further, it affects women more than men. Although a voluminous literature of studies is available evaluating the role of benzodiazepines (clonazepam and antidepressant (nortriptyline) in the treatment of RLS, but to the best of our knowledge, no comparative study is available comparing both of these drugs for efficacy and safety for the treatment of RLS QoL among 40 + years old women. Materials and Methods: A prospective, randomized, open label comparative study was conducted in Postgraduate Department of Pharmacology in collaboration with the Department of General Medicine, Government Medical College, Jammu, a tertiary care teaching hospital for 1 year. Conclusion: Clonazepam proved to be significantly better in improving RLSQoL score. Difference between respective baselines of both groups was statistically insignificant.

[1]  Z. Yi,et al.  Effect of group cognitive-behavioral therapy on the quality of life and social functioning of patients with mild depression , 2016, Shanghai archives of psychiatry.

[2]  A. Kanungo,et al.  Equivalency of tricyclic antidepressants in open‐label neuropathic pain study , 2014, Acta neurologica Scandinavica.

[3]  M. Schuers,et al.  Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews , 2013, BMC Family Practice.

[4]  M. Buchfuhrer.  Strategies for the Treatment of Restless Legs Syndrome , 2012, Neurotherapeutics.

[5]  R. Wallace,et al.  Restless legs syndrome and functional limitations among American elders in the Health and Retirement Study , 2012, BMC Geriatrics.

[6]  L. Agüera-Ortiz,et al.  Prevalence and clinical correlates of restless legs syndrome among psychogeriatric patients , 2011, International journal of geriatric psychiatry.

[7]  Richard P Allen,et al.  Prevalence and disease burden of primary restless legs syndrome: Results of a general population survey in the United States , 2011, Movement disorders : official journal of the Movement Disorder Society.

[8]  A. Hicks,et al.  Update on the management of restless legs syndrome: existing and emerging treatment options , 2010, Nature and science of sleep.

[9]  J. Ulfberg,et al.  Health‐related quality of life and restless legs syndrome among women in Sweden , 2010, Psychiatry and clinical neurosciences.

[10]  Manabu Otsuki,et al.  Proposed dose equivalence between clonazepam and pramipexole in patients with restless legs syndrome , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[11]  D. Tu,et al.  Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial , 2009, The Lancet.

[12]  R. Dodel,et al.  Assessing health-related quality of life in patients with restless legs syndrome. , 2009, Sleep medicine.

[13]  S. Ratcliffe,et al.  Symptoms of Restless Legs Syndrome in Older Adults: Outcomes on Sleep Quality, Sleepiness, Fatigue, Depression, and Quality of Life , 2007, Journal of the American Geriatrics Society.

[14]  M. Max,et al.  Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain , 2007, PAIN.

[15]  Richard P Allen,et al.  Restless legs syndrome prevalence and impact: REST general population study. , 2005, Archives of internal medicine.

[16]  R. Allen,et al.  Validation of the Restless Legs Syndrome Quality of Life questionnaire. , 2005, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[17]  O. Doğu,et al.  Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  L. Vernich,et al.  Nortriptyline versus amitriptyline in postherpetic neuralgia , 1998, Neurology.

[19]  J. Horiguchi,et al.  Periodic Leg Movements in Sleep with Restless Legs Syndrome: Effect of Clonazepam Treatment , 1992, The Japanese journal of psychiatry and neurology.

[20]  P. Lavie,et al.  Double-blind evaluation of clonazepam on periodic leg movements in sleep. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[21]  M. Pondé,et al.  Akathisia and Restless Legs: Treatment of restless legs syndrome , 1995 .

[22]  D. Mannino,et al.  Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. , 2006, Chest.

[23]  M. Tohen,et al.  Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial. , 2004, Clinical therapeutics.